Market capitalization | €235.40m |
Enterprise Value | €231.50m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 57.88 |
EV/Sales (TTM) EV/Sales | 0.25 |
P/S ratio (TTM) P/S ratio | 0.26 |
P/B ratio (TTM) P/B ratio | 0.24 |
Revenue growth (TTM) Revenue growth | -10.00% |
Revenue (TTM) Revenue | €911.90m |
As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.
4 Analysts have issued a Euroapi forecast:
4 Analysts have issued a Euroapi forecast:
Dec '24 |
+/-
%
|
||
Revenue | 912 912 |
10%
10%
|
|
Gross Profit | 134 134 |
15%
15%
|
|
EBITDA | 47 47 |
43%
43%
|
EBIT (Operating Income) EBIT | -11 -11 |
378%
378%
|
Net Profit | -131 -131 |
31%
31%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company was founded in 1976 and is headquartered in Antony, France.
Head office | France |
CEO | David Seignolle |
Employees | 3,428 |
Founded | 2020 |
Website | www.euroapi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.